Your browser doesn't support javascript.
loading
Low doses of arsenic, via perturbing p53, promotes tumorigenesis.
Ganapathy, Suthakar; Li, Ping; Fagman, Johan; Yu, Tianqi; Lafontant, Jean; Zhang, Guojun; Chen, Changyan.
Afiliação
  • Ganapathy S; Center for Drug Development, Northeastern University, Boston, USA. Electronic address: s.ganapathy@neu.edu.
  • Li P; The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China; The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
  • Fagman J; The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
  • Yu T; Center for Drug Development, Northeastern University, Boston, USA.
  • Lafontant J; Center for Drug Development, Northeastern University, Boston, USA.
  • Zhang G; The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
  • Chen C; Center for Drug Development, Northeastern University, Boston, USA; The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
Toxicol Appl Pharmacol ; 306: 98-104, 2016 09 01.
Article em En | MEDLINE | ID: mdl-27425828
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arsênio / Carcinógenos / Proteína Supressora de Tumor p53 / Carcinogênese Limite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arsênio / Carcinógenos / Proteína Supressora de Tumor p53 / Carcinogênese Limite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2016 Tipo de documento: Article